SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-026696
Filing Date
2009-07-29
Accepted
2009-07-29 09:00:21
Documents
3
Period of Report
2009-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a53281e8vk.htm 8-K 11627
2 EX-99.1 a53281exv99w1.htm EX-99.1 15189
3 GRAPHIC a53281a5328101.gif GRAPHIC 6399
  Complete submission text file 0000950123-09-026696.txt   37527
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-15803 | Film No.: 09968752
SIC: 2834 Pharmaceutical Preparations